Opportunity overview
Provision of Community Intravenous Therapy (including Bisphosphonates) Service to be delivered to Greater Manchester Integrated Care Board. The Contract to be awarded as a result of this Procurement will have an initial term of three years commencing from 01 April 2026. The Authority will also have the option to extend the initial term of the Contract to a maximum term of five years to 31 March 2031 (3 years + 2 years). The anticipated, maximum total contract value (including any potential extensions) is £3,087,540. The indicative overall total contract value is made of £1,852,524 for the three years of contract (equal to £617,508 per annum) and £1,235,016 for the two-year extension. This is a Provider Selection Regime (PSR) open competitive intention to award notice, this notice serves as an intention to award under the PSR.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Mastercall Healthcare
- Contract value
- £3.1m
- Awarded
- Not supplied
- Contract signed
- 22 Sept 2025
- Award ID
- 059033-2025-1
- Status
- active
- Identifier
- GB-COH 05224356
- Location
- Stockport, UKD36, United Kingdom
Classification
- CPV85100000 — Health services
Lots
- The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of The Procurement Act 2023 Regulations do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on 6th October 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: nhsgm.procurement@nhs.net Award decision-makers: Corporate Director of Finance - Commissioning & Financial Assurance and the Executive Committee on behalf on NHS Greater Manchester Integrated Care Board. One conflict of interest was identified, this individual did not participate in the tender. The chosen provider was selected due to achieving the highest scores across the key criteria used. The provider has been assessed and passed against the relevant key criteria and basic criteria Key Criteria for the Competitive Process was: Section 1 - KC2 Section 2 - KC3 and 4 Section 3 - KC1 and KC3 Section 4 - KC1 and KC3 Section 5 - KC1 Section 6 - KC 1 and KC 3 Section 7 - KC4 Section 8 - KC1, KC3 and KC4 Section 9 - KC4 Section 10 - KC5£3.1m